PubMed

FDAリコールされた人工股関節装置のトレンド分析：後回帰レビュー

PMID: 41947919 · 2026-04-09

L, u, c, a, s, , P, , A, , L, o, r, i, m, e, r, ;, , K, a, l, t, e, r, , H, a, l, i, ;, , J, o, n, a, t, h, a, n, , R, a, s, p, a, n, t, i, ;, , S, a, m, , K, e, s, h, e, n, ;, , B, h, e, e, s, h, m, a, , R, a, v, i, ;, , L, a, z, a, r, o, s, , A, , P, o, u, l, t, s, i, d, e, s, ;, , J, o, h, n, a, t, h, a, n, , R, , L, e, x, ;, , N, i, k, o, l, a, o, s, , A, , S, t, a, v, r, o, p, o, u, l, o, s, ;, , G, e, o, r, g, e, , C, , B, a, b, i, s

学術誌JB & JS open access

年2026-04-09

PMID41947919

抄録

Hip arthroplasty implants are classified as Class III medical devices by the US Food and Drug Administration (FDA), requiring rigorous evaluation to ensure safety and efficacy. While these standards aim to ensure safety, device recalls remain an essential component of postmarket surveillance to address unforeseen performance issues. The objective of this study was to characterize the frequency, causes, and regulatory origins of FDA-recalled hip arthroplasty implants, identifying trends in device

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。